Abstract
Background
Breast cancer remains a major global health issue, with millions of cases diagnosed annually and limited diagnostic and treatment options, particularly in developing countries. This study aimed to evaluate the quality of breast cancer mobile health (m-health) applications using the Mobile Application Rating Scale (MARS) to guide healthcare stakeholders and patients identify high-quality mobile health applications that meet their needs.
Methods
A cross-sectional study was conducted in Mashhad, Iran, from February to July 2023, targeting breast cancer apps. Relevant apps were identified through comprehensive searches in databases and app stores based on predefined inclusion criteria. Four health information technology experts independently assessed the apps using MARS and the Feature-based Application Rating Method (FARM), with discrepancies resolved through discussion to ensure reliability. Data analysis included calculating mean scores, testing for data normality, and examining correlations between MARS and FARM dimensions using Spearman’s correlation.
Results
Of the 453 identified apps, 44 met the inclusion criteria. The average MARS and FARM score was 3.3 out of 5, indicating moderate quality. The functionality dimension scored highest at 4.1, reflecting strong technical performance; however, deficiencies in informational quality negatively impacted user trust and satisfaction. A strong correlation (r = 0.806) was observed between engagement and other quality dimensions, indicating variability in user engagement across apps.
Conclusions
While many breast cancer apps demonstrated high technical functionality, significant informational gaps reduced user trust and satisfaction. This study underscores the need for regulatory standards to ensure reliable content in breast cancer apps. Future app development should prioritize user engagement and informational quality to better meet patient needs.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer